Why the study?
The study was designed to analyze the effects of aerobic training with and without progression on systolic and diastolic blood pressure in hypertensive adults.
Does aerobic training with or without progression reduce systolic and diastolic blood pressure in hypertensive adults?
Does aerobic training with or without progression reduce systolic and diastolic blood pressure in hypertensive adults?
Aerobic training effectively reduces both systolic and diastolic blood pressure in hypertensive adults, regardless of whether training progression is applied.
Answers are grounded in this paper and cite their sources.
Both progressive and non-progressive aerobic training lower BP similarly in hypertension; confirms exercise efficacy while leaving optimal progression protocols open.
Objective: To analyze, through a systematic review with meta-analysis, the effects of aerobic training with and without progression on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in hypertensive adults. Method: The search for the studies was carried out in the PubMed, Cochrane Central, SPORTDiscus and LILACS databases. Clinical trials that analyzed the effect of aerobic training, lasting at least six weeks, on blood pressure in hypertensive individuals comparing with a control group without intervention were selected. The selection of studies and data extraction were carried out independently by two pairs of researchers. Results: Of the 13028 studies found, 24 were selected and included in this review. There was a reduction in SBP after aerobic training with progression (-10.67 mmHg; 95% CI -15.421, -5.926; p <0.001) and without progression (-10.17 mmHg; CI -12.213, -8.120; p <0.001). DBP also decreased after aerobic training with progression (-5.49 mmHg; 95% CI -8.663, -2.310; p <0.001) and without progression (-6.51 mmHg; 95% CI -9.147, -3.868; p < 0.001). Conclusion: Aerobic training promotes a reduction in the SBP and DBP levels of adults with hypertension, regardless of whether or not the training variables progression.
No takes yet. Share an insight, caveat, or question.
Barcelos et al. (2021) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: